
Avantor Inc. (AVTR) Stock Forecast & Price Target
Avantor Inc. (AVTR) Analyst Ratings
Bulls say
Avantor is a global provider of products and services to the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. They have a diverse product portfolio and a global footprint with over 300,000 customer locations in more than 180 countries. Despite facing headwinds from some of its product groups, management's turnaround efforts have shown positive results, leading to an increased target price from $8 to $15. However, there is still work to be done to fully realize Avantor's potential and investors should carefully monitor the company's execution and its ability to grow closer to bioprocess company growth rates.
Bears say
Avantor is undergoing a management turnaround, but the company still faces struggles in the near term due to customer funding uncertainty in academic and government markets, as well as competition in the biotech end market. While the company has made efforts to improve its operations, there are concerns around execution and a slower return to growth. Additionally, the company's valuation reflects a lower growth outlook and there is risk that end market recovery may take longer than expected.
This aggregate rating is based on analysts' research of Avantor Inc. and is not a guaranteed prediction by Public.com or investment advice.
Avantor Inc. (AVTR) Analyst Forecast & Price Prediction
Start investing in Avantor Inc. (AVTR)
Order type
Buy in
Order amount
Est. shares
0 shares